Unique ID issued by UMIN | UMIN000031890 |
---|---|
Receipt number | R000036409 |
Scientific Title | Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty |
Date of disclosure of the study information | 2018/03/25 |
Last modified on | 2023/04/09 21:28:43 |
Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty
Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty
Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty
Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty
Japan |
knee osteoarthritis or knee rheumatoid arthritis
Orthopedics | Anesthesiology | Operative medicine |
Others
NO
The aim is to clarify the superior or non-inferior efficacy of the early discharge after total knee arthroplasty with administrating different volume of levobupivacaine in femoral triangle block for
Efficacy
Confirmatory
Pragmatic
Phase III
Attainment time of early discharge criteria
Postoperative pain score (VRS)(Postoperative 1 hour, time point per 8 hours till postoperative 72 hours)
Postoperative motor function (24, 48, 72 hours)
Postoperative rehabilitation score and muscle power(24, 48, 72 hours)
Consumption of postoperative additional analgesics(72 hours)
Complication(72 hours)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Dose comparison
YES
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Medicine |
Group LV(Low volume): preoperative femoral triangle block with 0.5% levobupivacaine 5mL
Group HV(High volume): preoperative femoral triangle block with 0.125% levobupivacaine 20mL
20 | years-old | <= |
100 | years-old | > |
Male and Female
1.Patients scheduled unilateral total knee arthroplasty at Daiyukai General Hospital
2.Adults (>=20 years) with American Society of Anaesthesiologists Physical Status Classification I-III
3.Participants were scheduled for primary unilateral TKA for osteoarthritis
4.Written informed consent is provided
1.Inability to communicate lucidly
2.Bilateral TKA
3.revision knee arthroplasty
4.Under 20 years old
5.Allergy to any of the drugs used in this study
6.ASA-PS > III
7.Chronic opioid use
8.Diabetes mellitus with sensory disorders
9.Neurological disability
10.Infections around femoral crease
11.Platelet < 5.0 * 10^4 /mcl
12.Pregnancy, possibility of pregnancy, or breast-feeding women
13.Contraindications to peripheral nerve blocks
120
1st name | Norihiro |
Middle name | |
Last name | Sakai |
Daiyukai General Hospital
Dep. Anaesthesiplogy
491-8551
1-9-9, Sakura, Ichinomiya, Aichi, Japan
+81-586-72-1211
sakayline@anes.med.osaka-u.ac.jp
1st name | Norihiro |
Middle name | |
Last name | Sakai |
Daiyukai General Hospital
Dep. Anaesthesiplogy
491-8551
1-9-9, Sakura, Ichinomiya, Aichi, Japan
+81-586-72-1211
http://www.wb.commufa.jp/dykmasui/
sakayline@anes.med.osaka-u.ac.jp
Daiyukai General Hospital
Daiyukai General Hospital
Self funding
Institution of Review Board of Daiyukai general Hospital
1-9-9, Sakura, Ichinomiya, Aichi, Japan
+81-586-72-1211
extensor2@yahoo.co.jp
NO
総合大雄会病院(愛知県)
2018 | Year | 03 | Month | 25 | Day |
Unpublished
Completed
2018 | Year | 03 | Month | 01 | Day |
2018 | Year | 03 | Month | 07 | Day |
2018 | Year | 03 | Month | 21 | Day |
2019 | Year | 12 | Month | 31 | Day |
2020 | Year | 03 | Month | 31 | Day |
2020 | Year | 03 | Month | 31 | Day |
2020 | Year | 03 | Month | 31 | Day |
2018 | Year | 03 | Month | 25 | Day |
2023 | Year | 04 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036409